Literature DB >> 18266764

Active gamma-secretase is localized to detergent-resistant membranes in human brain.

Ji-Yeun Hur1, Hedvig Welander, Homira Behbahani, Mikio Aoki, Jenny Frånberg, Bengt Winblad, Susanne Frykman, Lars O Tjernberg.   

Abstract

Several lines of evidence suggest that polymerization of the amyloid beta-peptide (Abeta) into amyloid plaques is a pathogenic event in Alzheimer's disease (AD). Abeta is produced from the amyloid precursor protein as the result of sequential proteolytic cleavages by beta-secretase and gamma-secretase, and it has been suggested that these enzymes could be targets for treatment of AD. gamma-Secretase is an aspartyl protease complex, containing at least four transmembrane proteins. Studies in cell lines have shown that gamma-secretase is partially localized to lipid rafts, which are detergent-resistant membrane microdomains enriched in cholesterol and sphingolipids. Here, we studied gamma-secretase in detergent-resistant membranes (DRMs) prepared from human brain. DRMs prepared in the mild detergent CHAPSO and isolated by sucrose gradient centrifugation were enriched in gamma-secretase components and activity. The DRM fraction was subjected to size-exclusion chromatography in CHAPSO, and all of the gamma-secretase components and a lipid raft marker were found in the void volume (> 2000 kDa). Co-immunoprecipitation studies further supported the notion that the gamma-secretase components are associated even at high concentrations of CHAPSO. Preparations from rat brain gave similar results and showed a postmortem time-dependent decline in gamma-secretase activity, suggesting that DRMs from fresh rat brain may be useful for gamma-secretase activity studies. Finally, confocal microscopy showed co-localization of gamma-secretase components and a lipid raft marker in thin sections of human brain. We conclude that the active gamma-secretase complex is localized to lipid rafts in human brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266764     DOI: 10.1111/j.1742-4658.2008.06278.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  45 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

2.  Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Authors:  Ji-Yeun Hur; Yasuhiro Teranishi; Takahiro Kihara; Natsuko Goto Yamamoto; Mitsuhiro Inoue; Waltteri Hosia; Masakazu Hashimoto; Bengt Winblad; Susanne Frykman; Lars O Tjernberg
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity.

Authors:  Gintaras Valincius; Frank Heinrich; Rima Budvytyte; David J Vanderah; Duncan J McGillivray; Yuri Sokolov; James E Hall; Mathias Lösche
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

Review 4.  Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

Authors:  Michelle M Mielke; Constantine G Lyketsos
Journal:  Neuromolecular Med       Date:  2010-06-23       Impact factor: 3.843

Review 5.  Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease.

Authors:  Anna Colell; Anna Fernández; José C Fernández-Checa
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

6.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

7.  gamma-Secretase dependent production of intracellular domains is reduced in adult compared to embryonic rat brain membranes.

Authors:  Jenny Frånberg; Helena Karlström; Bengt Winblad; Lars O Tjernberg; Susanne Frykman
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

Review 8.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

9.  Insulin-like growth factor-I-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes.

Authors:  Robert J Romanelli; Kedar R Mahajan; Clifton G Fulmer; Teresa L Wood
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

10.  Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface.

Authors:  Cristina Guardia-Laguarta; Mireia Coma; Marta Pera; Jordi Clarimón; Lidia Sereno; José M Agulló; Laura Molina-Porcel; Eduard Gallardo; Amy Deng; Oksana Berezovska; Bradley T Hyman; Rafael Blesa; Teresa Gómez-Isla; Alberto Lleó
Journal:  J Neurochem       Date:  2009-04-27       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.